Skip to main content
. Author manuscript; available in PMC: 2018 Jun 4.
Published in final edited form as: Neuropediatrics. 2017 Apr 10;48(3):166–184. doi: 10.1055/s-0037-1601449

Fig. 3.

Fig. 3

Age at presentation and associated disability. (A) Age at presentation in patients developing disease after a period of clearly normal development. (B) Assessment of gross motor function, manual ability, and communication status in living patients with mutations in ADAR1 over 1 year of age.